Clinical Trials
2 trialsNCT06170190 2025-11-17
A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumours
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Completed
NCT05636215 2025-03-20
A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Recruiting